Innovations in Immunology

GeoVax is developing the next generation of vaccines and immunotherapies to address unmet medical needs in cancer and infectious disease.

Our current development programs are focused on vaccines against COVID-19, Human Immunodeficiency Virus (HIV), Hemorrhagic Fever viruses such as Ebola (Zaire, Sudan), Marburg and Lassa, Malaria and Zika virus. We have also initiated programs to develop a multi-antigen vaccine to treat chronic Hepatitis B (HBV) infections, a vaccine to treat human papilloma virus (HPV)-induced cancers and a vaccine against tumor associated antigen MUC1 that is associated with metastatic progression of many cancer types including breast, ovarian, gastric, liver, pancreas, renal and  lymph nodes.
Innovative Science
World Class Collaborators
Fighting Cancer
HIV Clinical Trials
Copyright © GeoVax 2020. All Rights Reserved.